1.
Dermatol Online J
; 23(3)2017 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28329519
RESUMO
TNF-α-inhibitors are known to induce skin adverseeffects including psoriasis and alopecia areata. Here, wedescribe a unique pattern of hair loss that has psoriaticand alopecia areata-like features. Diagnosis requiresclinical-pathologic correlation and is supportedby increased catagen/telogen hairs, psoriasiformepidermal hyperplasia, perifollicular lymphocyticinfiltrate, and the presence of eosinophils and plasmacells. Although there are no treatment consensusguidelines, management options include stoppingtherapy, switching to a different TNF-α inhibitor orustekinumab (in severe cases), or continuing TNF-αinhibitor therapy with addition of topical, intralesional,or systemic immunosuppressants.
Assuntos
Adalimumab/efeitos adversos , Alopecia/induzido quimicamente , Antirreumáticos/efeitos adversos , Doença de Crohn/tratamento farmacológico , Alopecia/diagnóstico , Alopecia/tratamento farmacológico , Alopecia/patologia , Feminino , Glucocorticoides/uso terapêutico , Humanos , Injeções Intralesionais , Triancinolona/uso terapêutico , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adulto Jovem
2.